Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report
Open Access
- 17 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 4 (FI1) , 1-6
Abstract
Background: SARS-CoV-2 is known to induce a cytokine storm, a hyperinflammatory state driven by up-regulation of interleukin 6 (IL-6) and immunomodulatory chemokines that may result in acute heart failure. Case summary: A 65-year-old woman with confirmed SARS-CoV-2 developed shock with multiorgan system failure, including acute biventricular heart failure, 2 weeks after the initial onset of fever, cough, and shortness of breath. The patient experienced myocardial recovery within 48 h after administration of tocilizumab, a humanized monoclonal anti-IL-6 receptor antibody, and multiple supportive vasoactive medications. Discussion: The differential diagnosis of acute heart failure in critically ill patients with COVID-19 infection is broad, including sepsis-induced cardiomyopathy, Takotsubo syndrome, viral lymphocytic myocarditis, and acute coronary syndrome. Immunomodulatory treatment with tocilizumab may benefit patients who develop cardiogenic shock associated with SARS-CoV-2-induced cytokine storm.Keywords
This publication has 14 references indexed in Scilit:
- COVID-19 and Cardiovascular DiseaseCirculation, 2020
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortalityInternational Journal of Antimicrobial Agents, 2020
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposalThe Journal of Heart and Lung Transplantation, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2015
- Brain natriuretic peptide in apical ballooning syndrome (Takotsubo/stress cardiomyopathy)Coronary Artery Disease, 2012
- Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkersEuropean Heart Journal, 2010
- Leukemia Inhibitory Factor and Interleukin-6 downregulate sarcoplasmic reticulum Ca 2+ ATPase (SERCA2) in cardiac myocytesBasic Research in Cardiology, 2000
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992